Page 7 - Faye Feller News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Faye feller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Faye Feller Today - Breaking & Trending Today

Geron Presentations at Upcoming EHA Annual Meeting to Report Updated Durability, Disease Modification and Favorable Patient Reported Outcomes (PRO) in Imetelstat-Treated Lower Risk MDS Patients in IMerge Phase 3

Longer follow-up data for 1-year transfusion independence in IMerge Phase 3, which demonstrated statistically significant and clinically meaningful continuous, durable efficacy

Strong. | May 11, 2023 ....

France General , United States , Faye Feller , Nicolas Chatain , Mikkael Sekeres , Nicolas Chapuis , Valeria Santini , Uwe Platzbecker , University Hospital Of Leipzig , Drug Administration , Sylvester Comprehensive Cancer Center , University Hospital Aachen , European Hematology Association , Geron Corporation Nasdaq , International Working Group , University Of Miami Health System , University Of Florence School Medicine , Geron Corporation , Annual Meeting , Executive Vice President , Chief Medical Officer , Lower Risk Myelodysplastic Syndromes , Transfusion Independence , Heavily Transfused Non Del , Erythropoiesis Stimulating Agents , University Hospital ,

Geron Corporation: Geron Presentations at Upcoming EHA Annual Meeting to Report Updated Durability, Disease Modification and Favorable Patient Reported Outcomes (PRO) in Imetelstat-Treated Lower Risk MDS Patients in IMerge Phase 3

Longer follow-up data for 1-year transfusion independence (TI) in IMerge Phase 3, which demonstrated statistically significant and clinically meaningful continuous, durable efficacy Strong ....

France General , United States , Nicolas Chatain , Faye Feller , Uwe Platzbecker , Valeria Santini , Kaplan Meier , Aaron Feingold , Mikkael Sekeres , Nicolas Chapuis , Geron Corporation Nasdaq , International Working Group , European Hematology Association , University Hospital Aachen , University Hospital Of Leipzig , Sylvester Comprehensive Cancer Center , Exchange Commission , Drug Administration , University Of Florence School Medicine , University Of Miami Health System , Eastern Time , Annual Meeting , Executive Vice President , Chief Medical Officer , Data Lower Risk Myelodysplastic Syndromes , Transfusion Independence ,

Geron Corporation (NASDAQ:GERN) Q4 2022 Earnings Call Transcript

Operator: Good afternoon. My name is Emma and I will be your conference operator today. ....

Aaron Feingold , Kalpit Patel , Joel Beatty , John Scarlett , Stephen Willey , Faye Feller , Geron Corporation , Geron Corporation Fourth Quarter , Corporate Communications , Geron Corp , Md Anderson Cancer Center , Call Transcript March , Fourth Quarter , Full Year , Investor Relations , Vice President , Chief Executive Officer , Olivia Bloom , Executive Vice President , Chief Financial Officer , Chief Medical Officer , Anil Kapur , Corporate Strategy , Chief Commercial , Risk Factors , Chief Medical ,

Geron (GERN) Q4 2022 Earnings Call Transcript

GERN earnings call for the period ending December 31, 2022. ....

Kalpit Patel , John Scarlett , Stephen Willey , Faye Feller , Gil Blum Needham , Kalpit Patelb Riley , Aaron Feingold , Joel Beatty , Gil Blum , Steve Willey Stifel Financial Corp , Geron Corporation , Corporate Communications , Md Anderson Cancer Center , Company Analyst , Investor Relations , Olivia Bloom , Anil Kapur , Motley Fool Stock Advisor , Stock Advisor , Risk Factors , Chief Executive , Vice President , Chief Medical , Corporate Strategy , Chief Commercial , Chief Financial Officer ,

Telomerase inhibitor aids transfusion independence in LR MDS trial

Telomerase inhibitor imetelstat benefitted both major subtypes of lower risk MDS in a Phase III trial for the first time. ....

Johna Scarlett , Faye Feller , Uwe Platzbecker , Chief Executive , Chief Medical Officer ,